Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
BP-1002 by Bio-Path for Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma): Likelihood of Approval
BP-1002 is under clinical development by Bio-Path and currently in Phase I for Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma). According to...
BP-1002 by Bio-Path for Cutaneous T-Cell Lymphoma: Likelihood of Approval
BP-1002 is under clinical development by Bio-Path and currently in Phase I for Cutaneous T-Cell Lymphoma. According to GlobalData, Phase...
BP-1002 by Bio-Path for Peripheral T-Cell Lymphomas (PTCL): Likelihood of Approval
BP-1002 is under clinical development by Bio-Path and currently in Phase I for Peripheral T-Cell Lymphomas (PTCL). According to GlobalData,...